Our study on pancreatic cancer with collaborators at MIT, the Broad Institute, and Dana-Farmer Cancer Institute is now out in Cell – read the publication here and about the study here.
Learn about how Omer Yilmaz, Associate Professor of Biology at MIT, and Alex combine their expertise to tackle the largest problems in colon cancer here.
Our study on upper respiratory tract epithelial responses to SARS-CoV-2 infection receding mild and severe COVID-19 is now out in Cell. Read more about the study here, here, or here.
We’re incredibly grateful to receive an NIH Pioneer Award to define, at unprecedented resolution, how substance use disorders influence immune function and the response to HIV-1 and other pathogens by developing and applying innovative single-cell and bulk profiling and perturbation tools to inform the design of novel cure and prevention strategies. Read more here.
Our collaborative cell atlases of multiple organs at autopsy from COVID-19 donors – a joint work with many at the Broad Institute and the broader research community – is now available in Nature here, and its accompanying press release here.
Alex was recently features in Cell Systems’ “Voices” piece on the future of understanding cell behavior and cellular communities. Read his opinion, and that of other leading voices in the field, here.
Our pre-print detailing how different nasal epithelial and immune populations respond to SARS-CoV-2 infection across the spectrum of COVID-19 severity is now out on bioRxiv. This work was led by Carly Ziegler, Vincent Miao, Andrew Navia, and Josh Bromley in the Shalek lab. Read more here.
Our findings detailing the longitudinal response of myeloid cells to stroke are now out in Science Immunology. Read more about the study, co-led by post-doc Britt Goods, here.